Xuying Wan

3.2k total citations · 2 hit papers
36 papers, 2.3k citations indexed

About

Xuying Wan is a scholar working on Hepatology, Surgery and Epidemiology. According to data from OpenAlex, Xuying Wan has authored 36 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Hepatology, 13 papers in Surgery and 12 papers in Epidemiology. Recurrent topics in Xuying Wan's work include Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Hepatitis B Virus Studies (9 papers). Xuying Wan is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (19 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (13 papers) and Hepatitis B Virus Studies (9 papers). Xuying Wan collaborates with scholars based in China, Hong Kong and United States. Xuying Wan's co-authors include Kui Wang, Feng Shen, Yong Xia, Mengchao Wu, Dong Wu, Zhenlin Yan, Jun Li, Wan Yee Lau, Lehua Shi and Yizhou Wang and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Annals of Surgery.

In The Last Decade

Xuying Wan

36 papers receiving 2.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy

2013 839 citations Yizhou Wang, Jun Li et al. profile →
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus–Related Hepatocellular Carcinoma Within the Milan Criteria

2015 458 citations Zhengqing Lei, Jun Li et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuying Wan China	22	959	888	705	694	509	36	2.3k
Stefano Maria Giulini Italy	33	1.3k 1.4×	837 0.9×	630 0.9×	732 1.1×	552 1.1×	104	3.5k
Guido Alberto Massimo Tiberio Italy	29	1.3k 1.4×	612 0.7×	344 0.5×	770 1.1×	405 0.8×	87	2.8k
Hiroo Imazu Japan	22	909 0.9×	635 0.7×	693 1.0×	504 0.7×	672 1.3×	80	2.1k
Stéphanie Truant France	31	1.4k 1.4×	1.5k 1.7×	1.2k 1.6×	650 0.9×	936 1.8×	138	2.9k
Takaaki Higashi Japan	22	556 0.6×	1.1k 1.2×	732 1.0×	305 0.4×	995 2.0×	75	2.5k
Yanming Zhou China	31	1.6k 1.7×	1.0k 1.2×	1.6k 2.3×	992 1.4×	689 1.4×	112	3.3k
Kazunari Sasaki United States	31	1.5k 1.5×	1.9k 2.1×	1.3k 1.9×	552 0.8×	615 1.2×	211	3.3k
Stephen W. Fenwick United Kingdom	28	1.0k 1.0×	1.0k 1.1×	1.2k 1.7×	641 0.9×	236 0.5×	88	2.2k
Masato Nagino Japan	27	1.3k 1.3×	412 0.5×	1.1k 1.5×	759 1.1×	320 0.6×	127	2.6k
Kenei Furukawa Japan	23	728 0.8×	328 0.4×	1.1k 1.6×	392 0.6×	289 0.6×	203	1.9k

Countries citing papers authored by Xuying Wan

Since Specialization

Citations

This map shows the geographic impact of Xuying Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuying Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuying Wan more than expected).

Fields of papers citing papers by Xuying Wan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuying Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuying Wan. The network helps show where Xuying Wan may publish in the future.

Co-authorship network of co-authors of Xuying Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Xuying Wan. A scholar is included among the top collaborators of Xuying Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuying Wan. Xuying Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yang, Pinghua, Fei Teng, Yong Xia, et al.. (2022). Liver resection versus liver transplantation for hepatocellular carcinoma within the Milan criteria based on estimated microvascular invasion risks. Gastroenterology report. 11. goad035–goad035. 5 indexed citations

Zhao, Hetong, Xiaofeng Zhai, Binbin Cheng, et al.. (2020). Comparable effects of Jiedu Granule, a compound Chinese herbal medicine, and sorafenib for advanced hepatocellular carcinoma: A prospective multicenter cohort study. Journal of Integrative Medicine. 18(4). 319–325. 19 indexed citations

Li, Jun, Yefa Yang, Jingfeng Liu, et al.. (2020). Adjuvant 131I-metuximab for hepatocellular carcinoma after liver resection: a randomised, controlled, multicentre, open-label, phase 2 trial. The Lancet. Gastroenterology & hepatology. 5(6). 548–560. 51 indexed citations

Zou, Qifei, Ying Hou, Haibo Wang, et al.. (2018). Hydroxylase Activity of ASPH Promotes Hepatocellular Carcinoma Metastasis Through Epithelial-to-Mesenchymal Transition Pathway. EBioMedicine. 31. 287–298. 41 indexed citations

Lei, Zhengqing, Yong Xia, Anfeng Si, et al.. (2017). Antiviral therapy improves survival in patients with HBV infection and intrahepatic cholangiocarcinoma undergoing liver resection. Journal of Hepatology. 68(4). 655–662. 30 indexed citations

Wang, Qing, Jun Li, Zhengqing Lei, et al.. (2017). Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis. Annals of Surgical Oncology. 24(6). 1579–1587. 31 indexed citations

Li, Jun, Jian Zhou, Pinghua Yang, et al.. (2016). Nomograms for survival prediction in patients undergoing liver resection for hepatitis B virus related early stage hepatocellular carcinoma. European Journal of Cancer. 62. 86–95. 42 indexed citations

Zou, Qifei, Jun Li, Dong Wu, et al.. (2016). Nomograms for Pre-operative and Post-operative Prediction of Long-Term Survival of Patients Who Underwent Repeat Hepatectomy for Recurrent Hepatocellular Carcinoma. Annals of Surgical Oncology. 23(8). 2618–2626. 37 indexed citations

Liu, Jian, Kui Wang, Zhenlin Yan, et al.. (2016). Axl Expression Stratifies Patients with Poor Prognosis after Hepatectomy for Hepatocellular Carcinoma. PLoS ONE. 11(5). e0154767–e0154767. 44 indexed citations

10.

Xia, Yong, Zhengqing Lei, Qifei Zou, et al.. (2016). Antiviral Therapy Inhibits Viral Reactivation and Improves Survival after Repeat Hepatectomy for Hepatitis B Virus-Related Recurrent Hepatocellular Carcinoma. Journal of the American College of Surgeons. 224(3). 283–293e4. 25 indexed citations

11.

Yang, Pinghua, Jiliang Qiu, Jun Li, et al.. (2015). Nomograms for Pre- and Postoperative Prediction of Long-term Survival for Patients Who Underwent Hepatectomy for Multiple Hepatocellular Carcinomas. Annals of Surgery. 263(4). 778–786. 56 indexed citations

12.

Liu, Jian, Jingfeng Liu, Zhenlin Yan, et al.. (2015). Loss of function of Notch1 identifies a poor prognosis group of early stage hepatocellular carcinoma following hepatectomy. Oncology Reports. 34(6). 3174–3186. 5 indexed citations

13.

Li, Jun, Qing Wang, Zhengqing Lei, et al.. (2015). Adjuvant Transarterial Chemoembolization Following Liver Resection for Intrahepatic Cholangiocarcinoma Based on Survival Risk Stratification. The Oncologist. 20(6). 640–647. 38 indexed citations

14.

Li, Jun, Zhangjun Cheng, Zhenlin Yan, et al.. (2015). Serum thioredoxin is a diagnostic marker for hepatocellular carcinoma. Oncotarget. 6(11). 9551–9563. 48 indexed citations

15.

Wan, Xuying, et al.. (2010). Toxicity of bryostatin‐1 on the embryo‐fetal development of Sprague‐Dawley rats. Birth Defects Research Part B Developmental and Reproductive Toxicology. 89(3). 171–174. 6 indexed citations

16.

Zhu, Jiangbo, et al.. (2010). Evaluation of salidrosidein vitroandin vivogenotoxicity. Drug and Chemical Toxicology. 33(2). 220–226. 41 indexed citations

17.

Hou, Juan, et al.. (2009). Effects of titanium dioxide nanoparticles on development and maturation of rat preantral follicle in vitro.. Academic Journal of Second Military Medical University. 30(8). 869–873. 19 indexed citations

18.

Wan, Xuying, et al.. (2009). Evaluation of genotoxicity ofYanhuangliandehydrocavidine (YHL-DC)in vitroandin vivo. Drug and Chemical Toxicology. 33(1). 103–110. 3 indexed citations

19.

Wan, Xuying, et al.. (2009). Effect of astragaloside IV on the embryo‐fetal development of Sprague–Dawley rats and New Zealand White rabbits. Journal of Applied Toxicology. 29(5). 381–385. 39 indexed citations

20.

Zhang, Tianbao, et al.. (2006). [Detection of estrogenic effects of nonylphenol and bisphenol A in vitro reporter gene-based assays].. PubMed. 35(1). 13–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact